KEGG   DISEASE: Ulcerative colitis
H01466                      Disease                                
Ulcerative colitis
Inflammatory bowel disease (IBD) [DS:H01227]
Ulcerative colitis (UC) is one subtype of inflammatory bowel disease (IBD) whose pathogenesis is multifactorial and includes influences from genes, the environment, and the gut microbiome. In UC the inflammatory is limited to the mucosa of the colon and rectum. Clinically, the most common manifestation of UC may include bloody diarrhea, abdominal pain. In most severe cases, patients may experience fever, weight loss, anemia, and the intestine can get distended, presenting deep ulceration and possibly intestinal perforation.The long-time duration of the disease increases a colorectal cancer risk. UC is associated with a Th2 immune response. Recent genetic analyses have linked genes including interleukin 23 receptor, interleukin 10 and macrophage stimulating 1.
Immune system disease
Human diseases in ICD-11 classification [BR:br08403]
 13 Diseases of the digestive system
  Inflammatory bowel diseases
   DD71  Ulcerative colitis
    H01466  Ulcerative colitis
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  JAK-STAT signaling pathway
IL23R [HSA:149233] [KO:K05065]
IL10 [HSA:3586] [KO:K05443]
IL37 [HSA:27178] [KO:K05485]
MST1 [HSA:4485] [KO:K23441]
Fusobacterium varium [GN:fva]
Triamcinolone acetonide [DR:D00983]
Dexamethasone [DR:D00292]
Dexamethasone sodium phosphate [DR:D00975]
Hydrocortisone [DR:D00088]
Hydrocortisone acetate [DR:D00165]
Hydrocortisone sodium succinate [DR:D00978]
Prednisolone [DR:D00472]
Prednisolone sodium phosphate [DR:D00981]
Prednisone [DR:D00473]
Budesonide [DR:D00246]
Sulfasalazine [DR:D00448]
Mesalamine [DR:D00377]
Olsalazine sodium [DR:D00727]
Balsalazide disodium [DR:D02715]
Methylprednisolone [DR:D00407]
Methylprednisolone sodium succinate [DR:D00751]
Methylprednisolone acetate [DR:D00979]
Cortisone acetate [DR:D00973]
Infliximab [DR:D02598]
Adalimumab [DR:D02597]
Golimumab [DR:D04358]
Ustekinumab [DR:D09214]
Mirikizumab [DR:D11123]
Etrasimod arginine [DR:D10931]
Tofacitinib citrate [DR:D09783]
Upadacitinib hydrate [DR:D11048]
Vedolizumab [DR:D08083]
Other DBs
ICD-11: DD71
ICD-10: K51
MeSH: D003093
OMIM: 612261 619398
de Mattos BR, Garcia MP, Nogueira JB, Paiatto LN, Albuquerque CG, Souza CL, Fernandes LG, Tamashiro WM, Simioni PU
Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments.
Mediators Inflamm 2015:493012 (2015)
Abraham C, Cho JH
Inflammatory bowel disease.
N Engl J Med 361:2066-78 (2009)
PMID:17068223 (IL23R)
Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.
Science 314:1461-3 (2006)
PMID:18836448 (IL10)
Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, Domingues FS, Albrecht M, Nothnagel M, Ellinghaus D, Sina C, Onnie CM, Weersma RK, Stokkers PC, Wijmenga C, Gazouli M, Strachan D, McArdle WL, Vermeire S, Rutgeerts P, Rosenstiel P, Krawczak M, Vatn MH, Mathew CG, Schreiber S
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility.
Nat Genet 40:1319-23 (2008)
PMID:33674380 (IL37)
Zhang ZZ, Zhang Y, He T, Sweeney CL, Baris S, Karakoc-Aydiner E, Yao Y, Ertem D, Matthews HF, Gonzaga-Jauregui C, Malech HL, Su HC, Ozen A, Smith KGC, Lenardo MJ
Homozygous IL37 mutation associated with infantile inflammatory bowel disease.
Proc Natl Acad Sci U S A 118:e2009217118 (2021)
PMID:22237417 (MST1)
Hauser F, Deyle C, Berard D, Neukirch C, Glowacki C, Bickmann JK, Wenzel JJ, Lackner KJ, Rossmann H
Macrophage-stimulating protein polymorphism rs3197999 is associated with a gain of function: implications for inflammatory bowel disease.
Genes Immun 13:321-7 (2012)

» Japanese version

DBGET integrated database retrieval system